Camber Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$39.6M Buy
+500,000
New +$39.7M 3.72% 9
2022
Q2
Sell
-1,500,000
Closed -$123M 44
2022
Q1
$123M Sell
1,500,000
-1,000,000
-40% -$78.8M 4.45% 7
2021
Q4
$192M Buy
2,500,000
+1,000,000
+67% +$79.6M 6.58% 3
2021
Q3
$113M Hold
1,500,000
3.47% 9
2021
Q2
$117M Buy
1,500,000
+452,000
+43% +$33.6M 3.93% 9
2021
Q1
$77.1M Buy
+1,048,000
New +$77.3M 2.65% 14
2014
Q1
Sell
-1,037,834
Closed -$49.6M 43
2013
Q4
$49.6M Buy
+1,037,834
New +$47.4M 4.37% 9

Other funds holding MRK

Camber Capital Management's MRK Position: Q2 2025 in Review

Camber Capital Management opened a new position in Merck (MRK) in Q2 2025: 500,000 shares worth $39.6M. The stake represents 3.72% of the portfolio and ranks #9 among its holdings. This is a return to the name: Camber Capital Management previously reported a position in MRK as recently as Q1 2022.

Camber Capital Management first reported a position in MRK in Q4 2013 and has held it in 7 quarters since. The position peaked at $192M in Q4 2021. 3,332 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Camber Capital Management held 500,000 shares of Merck worth $39.6M as of Q2 2025.
  • Merck was a new Camber Capital Management position in Q2 2025.
  • Merck made up 3.72% of Camber Capital Management's portfolio in Q2 2025, its #9 holding.
  • Camber Capital Management first reported a position in Merck in Q4 2013 and has held it in 7 quarters since.
  • Camber Capital Management's Merck position peaked at $192M in Q4 2021.
  • 3,332 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Camber Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.